US 2014/0371241 A1Published application

Tec family kinase inhibitor adjuvant therapy

AssigneePharmacyclics, Inc.

InventorsJoseph J. BUGGY, Tarak D. Mody, Richard B. Love, John C. Byrd, Betty Chang, Jason A. Dubovsky, Natarajan Muthusamy, Amy Jo Johnson

Life of this patent

Estimating the term…

Abstract

Described herein are methods and compositions comprising a covalent TEC family kinase inhibitor for use in adjuvant therapy, including adjuvant cancer therapy, vaccination and treatment of immune disorders and pathogenic infections.

Claims6

Dependent claims

-33. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 14/198,559Filed 5 Mar 2014
Priority: 2 Nov 2012
Published: 18 Dec 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 29/00
Non-central analgesic, antipyretic or antiinflammatory agents
A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Family

Application61/722,107Us provisional application · filed 2 Nov 2012
Application61/785,868Us provisional application · filed 14 Mar 2013
Application14/070,420Continuation · filed 1 Nov 2013
Application14/198,559Continuation
US 2014/0134265 A1Published application
US 9,717,731 B2Related patent
US 2014/0371241 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results